# OnCo record cancerfind (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cancerfind/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cancerfind" ;
  schema:name "CancerFind"@en ;
  schema:description "IMBdx's blood test from South Korea, offered at screening centres there, which in a laboratory study detected nine in ten cancers including stage I."@en ;
  schema:url <https://onco.cc/drugs/cancerfind/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s12276-026-01674-7>, <https://doi.org/10.1038/s12276-023-01119-5>, <https://view.asiae.co.kr/en/article/2025100114010388952> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer early detection blood test (whole-genome methylation sequencing with fragmentomics)" ;
  schema:alternateName "CancerFind" ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cfdna-methylation-testing/>, <https://onco.cc/technologies/fragmentomics/> ;
  onco:companies <https://onco.cc/companies/imbdx/> .